Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

New Generation Chimeric Antigen Receptor T-Cell Therapy (CoupledCAR) Induces High Rate Remissions in Solid Tumor

Lei Xiao, PhD

Blood (2019) 134 (Supplement_1): 4631.

https://doi.org/10.1182/blood-2019-130703

Published: 2019

Journal Articles

Is There a Risk in Allogeneic PBPC Donation for Autoimmune Diseases Due to Short-Term Treatment with rhG-CSF? Preliminary Results of a Prospective Study in 100 Unrelated Stem Cell Donors.

Frank Kroschinsky, MD, Karsten Conrad, MD, Kirsten Poppe-Thiede, MD, Rainer Ordemann, MD, Andrea Schlaupitz, Gabi Rall, Claudia Rutt, Gerhard Ehninger, MD

Blood (2004) 104 (11): 2190.

https://doi.org/10.1182/blood.V104.11.2190.2190

Published: 2004

Journal Articles

Long-Term Follow-Up of 5,930 Unrelated Volunteers Donating Bone Marrow or Peripheral Blood Stem Cells.

Gerhard Ehninger, Gabi Rall, Frank Kroschinsky, Ulrich S. Schuler, Alexander Schmidt, Kristina Hoelig, Martin Bornhaeuser, Claudia Rutt

Blood (2004) 104 (11): 2754.

https://doi.org/10.1182/blood.V104.11.2754.2754

Published: 2004

Journal Articles

Clonal Gammopathies, Immune Cytopenias and Autoimmune Thyroid Dysfunction Following Alemtuzumab Containing Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

Mojtaba Akhtari, Kavita Raj, Wendy Ingram, Dragana Milojkovic, Ihab El-Hemaidi, Stephen Devereux, Antonio Pagliuca, Aloysius Ho, Ghulam Mufti

Blood (2004) 104 (11): 1839.

https://doi.org/10.1182/blood.V104.11.1839.1839

Published: 2004

Journal Articles

An intrinsic thyrotropin-mediated pathway of TNF-α production by bone marrow cells

Heuy-Ching Wang, Jolene Dragoo, Qin Zhou, John R. Klein

Blood (2003) 101 (1): 119–123.

https://doi.org/10.1182/blood-2002-02-0544

Published: 2003

NARROW

New Generation Chimeric Antigen Receptor T-Cell Therapy (CoupledCAR) Induces High Rate Remissions in Solid Tumor

Is There a Risk in Allogeneic PBPC Donation for Autoimmune Diseases Due to Short-Term Treatment with rhG-CSF? Preliminary Results of a Prospective Study in 100 Unrelated Stem Cell Donors.

Long-Term Follow-Up of 5,930 Unrelated Volunteers Donating Bone Marrow or Peripheral Blood Stem Cells.

Clonal Gammopathies, Immune Cytopenias and Autoimmune Thyroid Dysfunction Following Alemtuzumab Containing Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

An intrinsic thyrotropin-mediated pathway of TNF-α production by bone marrow cells

Email alerts

ASH Publications

American Society of Hematology

New Generation Chimeric Antigen Receptor T-Cell Therapy (CoupledCAR) Induces High Rate Remissions in Solid Tumor

Is There a Risk in Allogeneic PBPC Donation for Autoimmune Diseases Due to Short-Term Treatment with rhG-CSF? Preliminary Results of a Prospective Study in 100 Unrelated Stem Cell Donors.

Long-Term Follow-Up of 5,930 Unrelated Volunteers Donating Bone Marrow or Peripheral Blood Stem Cells.

Clonal Gammopathies, Immune Cytopenias and Autoimmune Thyroid Dysfunction Following Alemtuzumab Containing Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

An intrinsic thyrotropin-mediated pathway of TNF-α production by bone marrow cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only